Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2) - TSA BHF 2015/01
This study will compare tenecteplase, a newer clot-busting drug, with alteplase, which is currently the routine treatment used in hospitals.
The International Stroke Conference (ISC) 2018 took place in Los Angeles (24-26 January).
The ISC is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Check out some of the highlights from 2018.
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.